Wednesday, October 7, 2026
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Press releaseGlobeNewswire· March 24, 2026

Introducing Tenable Hexa AI: The Agentic Engine That Supercharges Security Productivity and Accelerates Risk Reduction

View original at globenewswire.com
Introducing Tenable Hexa AI: The Agentic Engine That Supercharges Security Productivity and Accelerates Risk Reduction SAN FRANCISCO, March 24, 2026 (GLOBE NEWSWIRE) -- RSA Conference Booth at #6155 — Tenable® Holdings, Inc…
Opening lines of the source · GlobeNewswire · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • The Tenable Exposure Data Fabric is the industry's most comprehensive repository of contextualized exposure data and intelligence

    60% confidence
  • Tenable protects over 40,000 customers around the globe

    60% confidence
  • Tenable Hexa AI marries an agentic orchestration engine to the powerful contextual exposure data fabric of Tenable One, automating complex tasks and orchestrating fixes across the enterprise, neutralizing exposures before they're exploited.

    60% confidence
  • There has never been a greater need to have an agentic system preemptively fixing issues before they are exploited. As AI-based attacks accelerate, the window from discovery to exploitation has effectively vanished.

    60% confidence
  • Tenable Hexa AI has fundamentally shifted how we deploy our security resources, powering and scaling efficiency across workflows. Reclaiming two days a month on a single process like asset tagging is a massive win for our team.

    60% confidence

Cited in these Via News reports

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Obesity and Immunology Readouts, Big Pharma M&A and AI-Designed Drugs Converge Into a Q4 2026 Catalyst Wave
Late-stage data and deal activity are clustering ahead of Q4 2026. Novo Nordisk's CagriSema won Best Abstract at EASD 2026 for its brain and body (fMRI/MRI) data, Lilly showed ADtouch results for EBGLYSS and agreed to buy Merida Biosciences for $2.9B, and Merck's tulisokibart hit its Phase 2b endpoints. A key regulatory catalyst follows: the FDA PDUFA date for the ivonescimab BLA on 2026-11-14. AI-designed rentosertib showing anti-aging effects adds a speculative AI-drug-discovery thread, while QAIAx's microcities trial and QIII pilot (planned 2027-01-01) are peripheral, forecast-only items.
Our read on the data ›
Signals we're tracking
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,351 source documents archived
Query this data → isubstrate.com